“5 Small and Midcap Pharma Stocks on the Verge of a Positive Shift” The pharmaceutical sector has endured prolonged challenges both in business performance and stock prices. Factors such as USFDA concerns and pricing pressures in US markets have plagued the industry. However, recent developments signal positive shifts for companies focusing on domestic...